Poster Presentations Session III
Poster Presentations Session III Tuesday, June 3, 2014
POSTERS SET-UP: 8:15 AM - 8:30 AM
POSTERS DISPLAY HOURS: 8:30 AM - 2:15 PM
POSTER AUTHOR DISCUSSION: 1:15 PM - 2:15 PM
POSTERS DISMANTLE: 2:15 PM


Poster display locations are shown below the poster codes
HEALTH SERVICES - Clinical Outcomes Studies
PHS1
A1
COMORBIDITIES AND HEALTH RESOURCE USE OF CHRONIC PLAQUE PSORIASIS PATIENTS IN CANADA: A MATCHED-COHORT STUDY
Gregory V1, Luciani L2, Barbeau M3, Petrella RJ4
1Novartis Pharmaceuticals Canada Inc., Dorval, QC, Canada, 2Université de Montréal, Montreal, QC, Canada, 3Novartis Pharmaceuticals Canada Inc., Montreal, QC, Canada, 4Lawson Health Research Institute, London, ON, Canada

PHS2
A2
RACIAL/ ETHNIC AND GENDER DIFFERENCES IN SEVERITY OF DIABETES-RELATED COMPLICATIONS, HEALTHCARE RESOURCE USE, AND COSTS AMONG MEDICARE ADVANTAGE RECIPIENTS
Hazel-Fernandez L1, Li Y2, Nero D3, Moretz C2, Slabaugh SL2, Meah Y4, Baltz J4, Costantino ME2, Patel N2, Bouchard JR5
1Comprehensive Health Insights, Humana, Miramar, FL, USA, 2Comprehensive Health Insights, Inc., Louisville, KY, USA, 3Magellan Health Services, Glenn Allen, VA, USA, 4Humana Inc., Louisville, KY, USA, 5Novo Nordisk Inc., Plainsboro, NJ, USA

PHS3
A3
MATERNAL MORBIDITY AND MORTALITY IN ECLAMPTIC PATIENTS: A CLINICAL STUDY IN BAHAWALPUR, SOUTHERN PUNJAB WITH SOCIO-ECONOMIC ASPECTS
Ashraf MN1, Batool F1, AlSharari S2
1The Islamia University of Bahawalpur, Bahawalpur, Pakistan, 2King Saud University, Riyadh, Saudi Arabia

PHS4
A4
IMPACT OF CARDIOVASCULAR COMORBIDITIES ON PATIENTS WITH TYPE 2 DIABETES MELLITUS: A SYSTEMATIC REVIEW
Vaidya V1, Gangan N2, Sheehan J3
1The University of Toledo, College of Pharmacy and Pharmaceutical Sciences, Toledo, OH, USA, 2The University of Toledo, Toledo, OH, USA, 3Bristol-Myers Squibb, Plainsboro, NJ, USA

PHS5
A5
THE ASSOCIATION BETWEEN LDL LEVELS AND CVD WITHIN THE COMMUNITY: AN OBSERVATIONAL STUDY
Leibowitz M1, Singer SR1, Karpati T1, Cohen C1, Feldman B1, Hoshen MB2, Bitterman H3, Suissa S4, Balicer RD1
1Clalit Health Services, Tel Aviv, Israel, 2Clalit Research Institute, Tel Aviv, Israel, 3Clalit Health Services Headquarters, Tel-Aviv, Israel, 4McGill University, Montreal, QC, Canada

PHS6
A6
NATURAL HISTORY OF METASTATIC PROSTATE CANCER IN CLINICAL PRACTICE
Ulcickas Yood M1, Cheng S2, Wells KE3, Casso D4, Woodcroft KJ3, Ukropec J2, Zyczynski T2
1EpiSource, LLC, Newton, MA, USA, 2Bristol-Myers Squibb Company, Princeton, NJ, USA, 3Henry Ford Health System, Detroit, MI, USA, 4Formerly of EpiSource, LLC, Newton, MA, USA

PHS7
A7
THE DIAGNOSTIC AND CLINICAL VALUE OF ANTI-MUTATED CITRULLINATED VIMENTIN ANTIBODIES IN RHEUMATOID ARTHRITIS
Chen Q1, Chen Y1, Peng J1, Chen Q2, Xiong Y2, Liu D1
1The Fifth Hospital of Xi’an, Xi'an, China, 2Xi'an Jiaotong university, Xi'an, China

PHS8
A8
SURVIVAL ANALYSIS FOR GASTRIC CANCER DETECTED BY ENDOSCOPIC SCREENING
Hamashima C1, Okamoto M2, Shabana M3, Osaki Y2, Kishimoto T2
1National Cancer Center of Japan, Tokyo, Japan, 2Tottori University, Yonago, Japan, 3San-in Rosai Hospital, Yonago, Japan

PHS9
WITHDRAWN

PHS10
A9
QUALITY OF PHARMACIST-MANAGED ANTICOAGULATION THERAPY IN LONG-TERM AMBULATORY SETTINGS: A SYSTEMATIC REVIEW
Cheng W, Manzoor BS, Cavallari L, Sharp L, Gerber B, Fitzgibbon ML, Schumock GT, Nutescu E
University of Illinois at Chicago, Chicago, IL, USA

PHS11
A10
THE IMPACT OF HOME MEDICATION REVIEW IN PATIENTS WITH TYPE 2 DIABETES MELLITUS LIVING IN RURAL AREAS OF KUANTAN, MALAYSIA
Nor Elina A1, Che Suraya MZ1, Ball PA2
1International Islamic University Malaysia, Kuantan, Pahang, Malaysia, 2Charles Darwin University, Darwin, Australia

PHS12
A11
INCRASED-DOSE HEPATITIS B VIRUS VACCINE IMPROVE THE IMMUNE RESPONSE IN HIV-INFECTED PATIENTS: A META-ANALYSIS
Zhao X, Lin P, Wu WK
St John's University, Jamaca, NY, USA

PHS13
A12
IMPROVING HEALTH CARE QUALITY, SAFETY, AND COSTS THROUGH THE INTEGRATION OF CLINICAL PHARMACY SERVICES
O'Callaghan R1, Joyce G1, Chen S2
1University of Southern California, Los Angeles, CA, USA, 2University of Southern California School of Pharmacy, Los Angeles, CA, USA

PHS14
A13
EPIDEMIOLOGY OF PSYCHIATRIC HOSPITALIZATIONS PUBLIC HEALTH SYSTEM IN BRAZIL BETWEEN 2010 AND 2012
Figueiredo AC
GlaxoSmithKline, Rio de Janeiro, Brazil

PHS15
A14
PNEUMOCOCCAL VACCINE TARGETING STRATEGY FOR THE OLDER ADULTS: CUSTOMIZED RISK PROFILING
Balicer RD1, Cohen C1, Leibowitz M1, Feldman B1, Brufman I1, Roberts CS2, Hoshen M1
1Clalit Health Services, Tel Aviv, Israel, 2Pfizer Inc., New York, NY, USA

PHS16
A15
WITHDRAWN

PHS17
A16
LONGITUDINAL ANALYSIS OF DENGUE FEVER INFECTIONS REPORTED IN THE UK BETWEN 2002 – 2013 USING THE HEALTH IMPROVEMENT NETWORK (THIN) PRIMARY CARE DATABASE
Ansell D, O'Leary C, Nasser A
CSD Medical Research UK, London, UK

PHS18
B1
ESTIMATING PUBLIC HEALTH AND MEDICAL DIRECT COST OF PNEUMOCOCCAL RELEVANT DISEASES FROM REAL WORLD DATABASE IN SHANGHAI, CHINA
Xu S1, Yang H1, Wang J1, Zhao Y2, Yu F2, Xu H2, Zhang Y2, Shi Q3, Xuan J4, Zheng W5, Ye L6
1Bureau of Health, Minhang District, Shanghai, China, 2Centers for Disease Control and Prevention, Minhang District, Shanghai, China, 3Pfizer China, Shanghai, China, 4Fudan University, School of Public Health, Shanghai, China, 5Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, TN, USA, 6Fudan University, Shanghai, China

PHS19
B2
SOCIO-ECONOMIC FACTORS ASSOCIATED WITH CHOLERA OUTBREAK IN SOUTHERN GHANA, 2012: A CASE-CONTROL STUDY
Davies-Teye BB1, Vanotoo L2, Yabani JB3, Kwakye-Maclean C2
1Ghana Health Service, Accra Metropolitan Directorate/Ghana College of Physicians and Surgeons, Accra, Ghana, 2Ghana Health Service, Greater Accra Regional Health Directorate, Accra, Ghana, 3Ghana Health Service, Tema Metropolitan Directorate, Tema, Ghana

PHS20
B3
ASSESSMENT OF DIABETES RISK FOR DETECTION OF TYPE 2 DIABETES MELLITUS IN YOUNG ADULTS
Ashok P
bharati vidyapeeth Medical college pune 43, Pune, Maharashtra, India

PHS21
B4
THE DETERMINANTS OF PLACE OF DEATH IN AN END-OF-LIFE OR PALLIATIVE CARE POPULATION
Costa V1, Holubowich C1, Kaulback K1, Pham B2, Sikich N1
1on behalf of the Health Quality Ontario Expert Panel on End-of-Life Care, Health Quality Ontario, Toronto, ON, Canada, 2University of Toronto, Toronto, ON, Canada

PHS22
B5
EVALUATION OF THE RATIONAL USE OF MEDICINES IN RENAL IMPAIRED PATIENTS IN THE PUBLIC SECTOR HOSPITALS OF PUNJAB, PAKISTAN
Haider SI, Ahmad M, Masood I
The Islamia University of Bahawalpur, Bahawalpur, Pakistan

PHS23
B6
DATA SOURCES AND STRUCTURE FOR POST-LICENSURE RAPID IMMUNIZATION SAFETY MONITORING (PRISM)
Selvan MS1, Baker M2, Lee G2, Yih K2, Cole D2, Nair V1, Walraven C3, Selvam N4
1Humana Inc, Miami, FL, USA, 2Harvard Pilgrim Healthcare, Boston MA 02215, TX, USA, 3Aetna, Blue Bell, PA, USA, 4HealthCore, Alexandria, VA, USA

HEALTH SERVICES - Cost Studies
PHS24
B7
COMPARATIVE EFFECTIVENESS AND COSTS OF STRATEGIES TO IMPROVE FOLLOW-UP FOR DIABETIC EYE CARE VISITS
Pizzi LT1, Zangalli C2, Murchison AP2, Hale N2, Hark L2, Dai Y2, Leiby BE1, Haller JA2
1Thomas Jefferson University, Philadelphia, PA, USA, 2Wills Eye Hospital, Philadelphia, PA, USA

PHS25
B8
ECONOMIC BURDEN OF CUSHING DISEASE IN A LARGE US MANAGED CARE HEALTH PLAN
Burton TM1, LeNestour E2, Neary MP3, Ludlam WH3
1OptumInsight, Waltham, MA, USA, 2inVentiv Health clinical, Nanterre, France, 3Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA

PHS26
B9
DIRECT INPATIENT AND OUTPATIENT COSTS RELATED WITH COPD EXACERBATIONS IN UKRAINE
Tolubaiev V, Zalis'ka O, Kacheray Y
Danylo Halytsky Lviv National Medical University, Lviv, Ukraine

PHS27
B10
ESTIMATING THE COST OF TREATING HYPOGLYCEMC EVENTS IN THE MEXICAN PUBLIC HEALTH CARE SYSTEM
Jimenez P1, Pastor V1, Luna G2
1Merck Sharp & Dohme, Mexico, Mexico, 2Links&Links, Mexico City, Mexico

PHS28
B11
ESTIMATING MORBIDITY COSTS ATTRIBUTABLE TO BREAST CANCER AMONG YOUNGER WOMEN AGED 18 TO 44 YEARS—UNITED STATES, 2000–2010
Ekwueme DU1, Trogdon J2, Khavjou O3, Guy Jr. G1, Li C1
1Centers for Disease Control and Prevention, Atlanta, GA, USA, 2University of North Carolina at Chapel Hill, Chapel Hill, GA, USA, 3RTI International, Chapel Hill, NC, USA

PHS29
B12
ASSESSING THE ECONOMIC BURDEN OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER AMONG CHILDREN IN THE UNITED STATES USING THE 2011 MEDICAL EXPENDITURE PANEL SURVEY (MEPS)
Gupte KP, Singh RR, Lawson KA
The University of Texas at Austin, Austin, TX, USA

PHS30
B13
ECONOMIC BURDEN OF STROKE: ANALYSIS FROM AN ADMINISTRATIVE DATABASE
Ciampichini R1, Cozzolino P1, Cortesi PA2, Fornari C2, Madotto F2, Chiodini V2, Mantovani LG3, Cesana G2
1Charta Foundation, Milan, Italy, 2University of Milano - Bicocca, Monza, Italy, 3Federico II University of Naples, Naples, Italy

PHS31
B14
CHANGES IN PREVALENCE OF DIABETIC COMPLICATIONS AND ASSOCIATED HEALTHCARE COSTS: "REAL-WORLD" DATA FROM A NATIONALLY-REPRESENTATIVE DIABETIC COHORT IN TAIWAN
Chen H1, Hsu WW2, Hsiao F1
1National Taiwan University, Taipei, Taiwan, 2National Taiwan Ocean University, Keelung, Taiwan

PHS32
B15
THE BURDEN OF ACUTE CORONARY SYNDROME FOR THE BRAZILIAN SUPPLEMENTARY HEALTH SYSTEM
Clark OA1, Piha T2, Miranda PA2
1Evidencias, Campinas, Brazil, 2AstraZeneca, Cotia, São Paulo, Brazil

PHS33
B16
THE COST OF HOSPITALIZATION DUE TO ACUTE RESPIRATORY INFECTIONS IN NORTHERN INDIA
Peasah SK1, Ram Purakayastha D2, Koul P3, Dawood F4, Saha S5, Broor S6, Rastogi V6, Widdowson M4, Lal R5, Krishnan A2
1Mercer University, Atlanta, GA, USA, 2All India Institute of Medical Sciences, New Delhi, India, 3Sheri Kashmir Institute of Medical Sciences, Srinagar, India, 4CDC, Atlanta, GA, USA, 5CDC India, New Delhi, India, 6Inclen Trust Labs, New Delhi, India

PHS34
C1
ECONOMIC BURDEN OF URTICARIA REQUIRING HOSPITALIZATION: ANALYSIS FROM AN ADMINISTRATIVE DATABASE
Ciampichini R1, Cozzolino P1, Cortesi PA2, Madotto F2, Fornari C2, Chiodini V2, Mantovani LG3, Cesana G2
1Charta Foundation, Milan, Italy, 2University of Milano - Bicocca, Monza, Italy, 3Federico II University of Naples, Naples, Italy

PHS35
C2
EPIDEMIOLOGIC AND ECONOMIC BURDEN ATTRIBUTABLE TO ATRIAL FIBRILLATION FROM ADMINISTRATIVE DATA
Ciampichini R1, Cozzolino P1, Cortesi PA2, Fornari C2, Madotto F2, Chiodini V2, Mantovani LG3, Cesana G2
1Charta Foundation, Milan, Italy, 2University of Milano - Bicocca, Monza, Italy, 3Federico II University of Naples, Naples, Italy

PHS36
C3
COSTS OF PNEUMOCOCCAL DISEASES FOR CHILDREN UNDER 5 YEARS IN COLOMBIA
Diaz JA1, Urrego Novoa JR1, Moreno JA2, Peralta Pizza F3, Reyes Sanchez JM3, Brown P4
1Facultad de Ciencias, Universidad Nacional de Colombia, Bogotá, Colombia, 2Universidad Distrital, Bogota, Colombia, 3Universidad Nacional de Colombia, Bogotá, Colombia, 4University of California, Merced, CA, USA

PHS37
C4
COSTS OF PSYCHIATRIC ASSISTANCE (PA) IN A BRAZILIAN HEALTHCARE PLAN (HP): A REAL WORLD DATA ANALYSIS
Viana Ad1, Lopes AF1, Matias CP1, Moreira VP1, Viana JL1, Clark OA2, Nishikawa AM3
1Unimed Fortaleza, Fortaleza, Brazil, 2Evidencias, Campinas, Brazil, 3Evidências, Campinas, Brazil

PHS38
C5
COST BURDEN OF CHRONIC PAIN IN A LARGE INTEGRATED DELIVERY SYSTEM IN THE US
Lamerato L1, Dryer R1, Mardekian J2, Hegeman-Dingle R2, Park PW2, Zlateva G2
1Henry Ford Health System, Detroit, MI, USA, 2Pfizer, Inc., New York, NY, USA

PHS39
C6
DIRECT MEDICAL COST OF COMPLICATIONS IN PATIENTS WITH NON VALVULAR ATRIAL FIBRILLATION AT THE SOCIAL SECURITY IN PERU
Sanabria C1, Cabrejos J1, Guevara C2, Olortegui A2, Garrido Lecca S3
1Universidad Nacional Mayor de San Marcos, Lima, Peru, 2Instituto Nacional Cardiovascular (INCOR) del Seguro Social de Salud del Perú, Lima, Peru, 3Bristol-Myers Squibb, Lima, Peru

PHS40
C7
HEALTH CARE PATHWAY AND COST OF OSTEOPOROSIS IN AN ITALIAN POPULATION
De Rosa M1, Cinconze E1, Rossini M2, Rossi E1, Adami S2
1CINECA Interuniversity Consortium, Casalecchio di Reno, Italy, 2Rheumatology Unit, Dpt Medicine, University of Verona, Verona, Italy

PHS41
C8
ECONOMIC IMPACT OF RHEUMATIC DISEASES IN MEXICO
Arreola-Ornelas H1, Camacho-Cordero LM2, Dorantes-Aguilar J1, Lemus-Carmona E3
1Fundación Mexicana para la Salud AC, Mexico City, Mexico, 2Health Consoultings, Mexico City, Mexico, 3Novartis Pharmaceuticals Corporation, Mexico City, Mexico

PHS42
C9
INCREMENTAL HEALTH CARE RESOURCE UTILIZATION ASSOCIATED WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE BY END-STAGE RENAL DISEASE STATUS
Iyer NN1, Vendetti NJ2, Levy DI2, Mardekian J3, Mychaskiw MA2, Thomas III J1
1Purdue University, College of Pharmacy and Regenstrief Center for Healthcare Engineering, Center for Health Outcomes Research and Policy, West Lafayette, IN, USA, 2Pfizer Inc., Collegeville, PA, USA, 3Pfizer, Inc., New York, NY, USA

PHS43
C10
TREATMENT PATTERNS AND COST OF CARE FOR PATIENTS WITH PANCREATIC CANCER
Seal BS1, Xia F1, Rietschel P1, Germino R1, Asche C2, D'Souza AO3, Morland K3, Eaddy M3
1Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ, USA, 2University of Illinois, Peoria, IL, USA, 3Xcenda, Palm Harbor, FL, USA

PHS44
C11
COST OF PATIENT CARE AT DIFFERENT STAGES OF TREATMENT WITHIN THE PUBLIC HEALTH MODEL OF HIV CARE; ANALYSIS FROM AN URBAN HIV CENTRE IN UGANDA
Parkes-Ratanshi RM1, Kakaire T1, Sempa J1, Musiime B1, Castelnuovo B1, Kuznik A2, Schlech W3
1Infectious Diseases Institute, Kampala, Uganda, 2Celgene Corporation, Summit, NJ, USA, 3Dalhousie University, Halifax, NS, Canada

PHS45
C12
PREDICTING HIGH COST ACCUMULATION: APPLICATION OF A GROUPING ALGORITHM FOR SURVIVAL DATA
Onukwugha E1, Qi R2, Jayasekera J1, Zhou S2
1University of Maryland School of Pharmacy, Baltimore, MD, USA, 2University of Maryland Baltimore County, Baltimore, MD, USA

PHS46
C13
MONTHLY COST OF THERAPY FOR PALLIATIVE TYPE II DIABETES IN MUMBAI:A SURVEY
Thakur TM1, Majumdar A2
1Bombay College of Pharmacy, University of Mumbai, Mumbai, India, 2Bombay College of Pharmacy, Mumbai, India

PHS47
C14
UTILIZATION, COSTS AND REIMBURSEMENT OF INPATIENT AND AMBULATORY TREATMENT OF ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS AMONG THE MEDICARE FEE-FOR-SERVICE POPULATION
LaPensee K1, Fan W1, Sulham K1, Ciarametaro M2, Hahn B2
1The Medicines Company, Parsippany, NJ, USA, 2Evidera, Bethesda, MD, USA

PHS48
WITHDRAWN

PHS49
C15
COSTS AND CONSEQUENCES OF ORAL ANTICOAGULATION IN ATRIAL FIBRILLATION AT THE SOCIAL SECURITY IN PERU
Sanabria C1, Cabrejos J1, Guevara C2, Olortegui A2, Garrido Lecca S3
1Universidad Nacional Mayor de San Marcos, Lima, Peru, 2Instituto Nacional Cardiovascular (INCOR) del Seguro Social de Salud del Perú, Lima, Peru, 3Bristol-Myers Squibb, Lima, Peru

PHS50
C16
ECONOMIC BURDEN OF EPIDEMIOLOGICAL CHANGES IN CHRONIC DISEASES IN MIDDLE INCOME COUNTRIES: THE MEXICAN CASE
Arredondo A, Orozco E
Instituto Nacional de Salud Pública, Cuernavaca, Mexico

PHS51
D1
COST-EFFECTIVENESS ANALYSIS OF GOVERNMENT INSURED ROUTINE EYE EXAMINATION: EVIDENCE FROM PRINCE EDWARDS ISLAND, CANADA
Thavorn K1, Tu HA2, Wedge R3, Jin Y2, Trope G2, El-Defrawy S4, Flanagan J5, Buys YM2
1St.Michael's Hospital, Toronto, ON, Canada, 2University of Toronto, Toronto, ON, Canada, 3Health PEI, Charlottetown, PE, Canada, 4Kensington Eye Institute, Toronto, ON, Canada, 5University of Toronto, ON, Canada

PHS52
D2
ECONOMIC EVALUATION OF A NEPHROPROTECTION PROGRAM IN PATIENTS OF THE MEXICAN INSTITUTE OF SOCIAL SECURITY WITH CHRONIC KIDNEY DISEASE
Azamar Alonso A1, Mena Brito J2, Soto Molina H3
1National Institute of Public Health, Cuernavaca, Mexico, 2Mexican Institute of Social Security, Federal District, Mexico, 3Universidad Autónoma Metropolitana, Mexico City, Mexico

PHS53
D3
COST AND EFFECTIVENESS OF AN EYE CARE ADHERENCE PROGRAM FOR SCHOOL CHILDREN WITH SIGNIFICANT VISUAL IMPAIRMENT
Amos T1, Pizzi LT1, Snitzer M2, Levin AV2
1Thomas Jefferson University, Philadelphia, PA, USA, 2Wills Eye Institute, Philadelphia, PA, USA

PHS54
D4
COST-EFFECTIVENESS OF A CARE PROGRAM FOR HIV/AIDS PATIENTS INSURED BY A HEALTH MAINTENANCE ORGANIZATION IN COLOMBIA COMPARING THREE HEALTH CARE PROVIDERS NATIONWIDE
Guarin NE1, Moreno JA1, Diaz JA2, Munoz Galindo IM1, Arevalo HO1
1Salud Total, Bogota, Colombia, 2Facultad de Ciencias, Universidad Nacional de Colombia, Bogotá, Colombia

PHS55
D5
COST-EFFECTIVENESS OF BREAST MRI AND MAMMOGRAPHY FOR SCREENING HIGH RISK POPULATION
Jiao X, Hay J
University of Southern California, Los Angeles, CA, USA

PHS56
D6
THE COST-EFFECTIVENESS OF ANTENATAL SYPHILIS SCREENING USING POINT-OF-CARE TESTING IN LOW AND MIDDLE INCOME COUNTRIES IN ASIA
Muhumuza C1, Komakeck H1, Lamorde M2, Marques E3, Kuznik A4
1Makerere University, Kampala, Uganda, 2Infectious Diseases Institute, Kampala, Uganda, 3University of Bristol, Bristol, UK, 4Celgene Corporation, Summit, NJ, USA

PHS57
D7
ECONOMIC EVALUATION OF A COMPREHENSIVE CARE AT HOME PROGRAM IN PATIENTS OF THE MEXICAN INSTITUTE OF SOCIAL SECURITY WITH MULTIPLE SCLEROSIS
Azamar Alonso A1, Mena Brito J2, Soto Molina H3
1National Institute of Public Health, Cuernavaca, Mexico, 2Mexican Institute of Social Security, Federal District, Mexico, 3Universidad Autónoma Metropolitana, Mexico City, Mexico

PHS58
D8
COST-EFFECTIVENESS ANALYSIS OF A HOSPITAL CARE AT HOME PROGRAM VS. INPATIENT HOSPITAL CARE IN PATIENTS OF THE MEXICAN INSTITUTE OF SOCIAL SECURITY IN MEXICO CITY
Azamar Alonso A1, Mena Brito J2, Soto Molina H3
1National Institute of Public Health, Cuernavaca, Mexico, 2Mexican Institute of Social Security, Federal District, Mexico, 3Universidad Autónoma Metropolitana, Mexico City, Mexico

PHS59
D9
COST-EFECTIVENESS ANALYSIS OF INSULIN GLARGINE (LANTUS) INITIATION BY PHARMACISTS IN A CANADIAN SETTING: THE RXING STUDY
Al Hamarneh Y1, Sauriol L2, Tsuyuki R1, Brown ST3
1University of Alberta, Edmonton, AB, Canada, 2Sanofi, Laval, QC, Canada, 3Ethicon, Inc, Somerville, NJ, USA

PHS60
D10
COST-EFFECTIVENESS ANALYSIS OF MASS SCREENING PROGRAM FOR TYPE 2 DIABETES MELLITUS IN SOUTH KOREA
Jang S1, Park S2, Jo J1, Yang D1, Yoo S1, Bahk J1, Hahn S1, Lee T1
1Seoul National University, Seoul, South Korea, 2Seoul National University Hospital, Seoul, South Korea

PHS61
D11
COST-EFFECTIVENESS OF EARLY DETECTION OF ENDOMETRIOSIS: A SYSTEMATIC REVIEW
Lyttle-Nguessan C, Campbell ES
Florida A&M University, Tallahassee, FL, USA

PHS62
D12
COST EFFECTIVENESS ANALYSIS OF HIV AND AIDS TREATMENT IN KENYA: A COMPARATIVE STUDY OF MBAGATHI DISTRICT AND MOI TEACHING AND REFFERAL HOSPITALS
Owiti EA
The University of Nairobi, Nairobi, Kenya

PHS63
D13
COST-EFFECTIVENESS ANALYSIS OF A PHARMACIST-LED INTERVENTION ON IMPROVING INHALER ADHERENCE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
van Boven JF1, Tommelein E2, Boussery K2, Mehuys E2, Vegter S1, Brusselle GG3, Rutten-van Mölken MP4, Postma MJ1
1University of Groningen, Groningen, The Netherlands, 2Ghent University, Ghent, Belgium, 3Ghent University Hospital, Ghent, Belgium, 4Erasmus University Rotterdam, Rotterdam, The Netherlands

PHS64
D14
SCREENING FOR ABDOMINAL AORTIC ANEURYSM: A COST-EFFECTIVENESS ANALYSIS
Ingels JB, Ebell MH, Corso PS
University of Georgia, Athens, GA, USA

PHS65
D15
GENERALIZED COST-EFFECTIVENESS ANALYSIS FOR CARE OF MAJOR CANCERS AND OTHER MAJOR ILLNESSES IN TAIWAN
Hung M1, Lai W2, Hwang J3, Wang J4
1Department of Public Health, National Cheng Kung University Medical College, Tainan, Taiwan, 2Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan, 3Institute of Statistical Science, Academia Sinica, Taipei, Taiwan, 4National Cheng Kung University College of Medicine, Tainan, Taiwan

PHS66
WITHDRAWN

PHS67
D16
STRATEGIES AND INTERVENTIONS TO REDUCE THE SOCIO ECONOMIC IMPACT OF ANXIETY AND DEPRESSION AT THE WORKPLACE
Razzouk D1, Pinheiro Md2
1Universidade Federal de Sao Paulo, SAO PAULO, Brazil, 2Fundação Getulio Vargas, SAO PAULO, Brazil

PHS68
E1
EFFICIENCY OF THE BRAZILIAN SYSTEM OF RENAL TRANSPLANTATION: AN ANALYSIS USING DEA AND MALMQUIST INDEX METHOD (2006-2011)
Balbinotto G1, Favoretto C2, Sampaio L3
1UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL, PORTO ALEGRE, Brazil, 2CESUMAR, PORTO ALEGRE, Brazil, 3UFRN, PORTO ALEGRE, Brazil

PHS69
E2
ECONOMIC IMPACT OF PATIENTS WITH TUBEROUS SCLEROSIS COMPLEX (TSC) IN THE UK: A RETROSPECTIVE DATABASE ANALYSIS IN THE CLINICAL PRACTICE RESEARCH DATALINK (CPRD)
Demuth D1, Nasuti P1, Lucchese L1, Gray L2, Pinnegar A2, Magestro M3
1IMS Health, London, UK, 2Novartis Pharmaceuticals UK Limited, Frimley, UK, 3Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA

PHS70
WITHDRAWN

PHS71
E3
HIGH COST PATIENTS AND COST PATTERNS FROM PEDIATRIC TO ADULT CARE IN A MEDICAID POPULATION WITH SICKLE CELL DISEASE
Blinder M1, Sasane M2, Fortier J3, Paley C2, Duh MS4, Vekeman F3
1Washington University in St. Louis, St. Louis, MO, USA, 2Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, 3Groupe d’analyse, Ltée, Montréal, QC, Canada, 4Analysis Group, Inc., Boston, MA, USA

PHS72
E4
THE COST OF MULTIPLE LYMPH NODE BIOPSY PROCEDURES TO THE US HEALTHCARE SYSTEM AMONG PATIENTS DIAGNOSED WITH LYMPHOMA: A COMMERCIAL HEALTHCARE DATABASE ANALYSIS
Chastek B1, Byfield S1, Bodnar CE2
1OptumInsight, Eden Prairie, MN, USA, 2BresMed, Sheffield, UK

PHS73
E5
COSTS OF PILOT PROGRAMS IN CHICAGO-BASED CENTERS FOR POPULATION HEALTH AND HEALTH DISPARITIES: A CASE FOR TEAM-CARE?
Walton S1, Johnson TJ2, Powell LH3, Emery EE3, Rothschild SK3, Joyce B4, Li C3
1University of Illinois at Chicago, Chicago, IL, USA, 2Rush University, Chicago, IL, USA, 3Rush, Chicago, IL, USA, 4University of Illinois Chicago, Chicago, IL, USA

PHS74
E6
TREATMENT PATTERNS AND HEALTHCARE RESOURCE UTILIZATION OF PATIENTS WITH NEUROENDOCRINE TUMORS IN THE UNITED STATES
Chuang C1, Dinet J2, Bhurke S1, Chen S1, Brulais S3, Gabriel S3
1Evidera, Lexington, MA, USA, 2IPSEN Pharma, Boulogne-Billancourt, France, 3IPSEN Pharma, Boulogne Billancourt, France

PHS75
E7
UTILIZATION, COSTS AND REIMBURSEMENT OF INPATIENT TREATMENT OF ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS AMONG THE MEDICARE FEE-FOR-SERVICE POPULATION
LaPensee K1, Fan W1, Ciarametaro M2, Hahn B2
1The Medicines Company, Parsippany, NJ, USA, 2Evidera, Bethesda, MD, USA

PHS76
WITHDRAWN

PHS77
E8
FACTORS RELATED WITH DIRECT COSTS OF RESIDENTIAL MENTAL HEALTH SERVICES IN SÃO PAULO CITY, BRAZIL: DOES RESIDENT PROFILE AFFECT COSTS?
Razzouk D, Sousa A, Cardoso A, Oliveira GG, Mari JJ
Universidade Federal de Sao Paulo, SAO PAULO, Brazil

PHS78
E9
DIFFERENCES IN THE UTILIZATION OF PREVENTIVE SERVICES FOR US VETERANS AND NON-VETERANS
Shah RT, Parker WM
Albany College of Pharmacy and Health Sciences, Albany, NY, USA

PHS79
E10
IMPACT OF A RHEUMATOID ARTHRITIS PATHWAY ON COST OF CARE
Feinberg BA1, Olson T1, Matsumoto AK2, Baraf HS2, Miller PB3, Winn D3
1Cardinal Health, Dublin, OH, USA, 2Arthritis and Rheumatism Associates, Wheaton, MD, 3CareFirst BlueCross BlueShield, Baltimore, MD, USA

HEALTH SERVICES - Patient-Reported Outcomes & Patient Preference Studies
PHS80
E11
ASSOCIATION BETWEEN PERSISTENT ANNUAL TO BIENNIAL MAMMOGRAPHY SCREENING AND STAGE AT DIAGNOSIS AMONG ELDERLY WOMEN WITH BREAST CANCER
Vyas A1, Madhavan S1, Sambamoorthi U2, Pan X1, Regier M2, Hazard H2
1West Virginia University School of Pharmacy, Morgantown, WV, USA, 2West Virginia University, Morgantown, WV, USA

PHS81
E12
IMPACT OF PHARMACIST-CALL INTERVENTION PROGRAM ON NEW-TO-THERAPY PATIENTS' MEDICATION ADHERENCE
Taitel M, Jiang JZ, Rudkin K
Walgreen Co., Deerfield, IL, USA

PHS82
E13
SYSTEMATIC LITERATURE REVIEW OF COMPLIANCE AND PERSISTENCE PROGRAMS IN INFLAMMATION AND IMMUNOLOGY
Burudpakdee C1, Kaura S2, Gala S1, Nanavaty M1, Khan ZM2
1MKTXS, Raritan, NJ, USA, 2Celgene Corporation, Summit, NJ, USA

PHS83
E14
THE REACH OF ADEQUATE PHARMACOLOGICAL ADHERENCE AND THE TIME NECESSARY TO IMPROVE IT AFTER PERFORMING A PHARMACOTHERAPEUTIC FOLLOW UP TO A COHORT OF PATIENTS WITH HIV. FEBRUARY 2012 - JUNE 2013
Estrada JI1, Serna JA2, Restrepo AM1, Cardona M3
1CES University, Medellin, Colombia, 2UPB University, Medellin, Colombia, 3Antioquia University, Medellin, Colombia

PHS84
E15
FACTORS AFFECTING ACCESS AND ADHERENCE TO THE RECOMMENDED LEVEL OF DIABETES CARE IN TYPE II DIABETES ADULTS
Gala SD, Wu WK
St. John's University, Jamaica, NY, USA

PHS85
E16
DETERMINING PATIENT SATISFACTION, PERCEPTION OF VALUE, AND MONETARY WORTH ASSOCIATED WITH ADHERENCE PACKAGING AND PHARMACY SERVICES
Pinto SL, Bechtol RA, Omerza K, Conner T
The University of Toledo, College of Pharmacy and Pharmaceutical Sciences, Toledo, OH, USA

PHS86
F1
MILITARY VETERANS' PERCEPTIONS OF DISAGREEMENT WITH THEIR PROVIDER REGARDING THEIR MEDICALLY UNEXPLAINED SYMPTOMS ARE ASSOCIATED WITH LOWER SATISFACTION AND INTENTIONS TO ADHERE TO TREATMENT AND POORER HEALTH-OUTCOME EXPECTATIONS
Phillips LA1, McAndrew L2
1The George Washington University, Washington, DC, USA, 2The State University of New York at Albany, Albany, NY, USA

PHS87
F2
ESTIMATING LONG-TERM FUNCTIONAL IMPAIRMENTS OF RHEUMATOID ARTHRITIS: INTEGRATION OF NATIONWIDE SURVIVAL WITH HEALTH ASSESSMENT FROM CLINICAL COHORT
Hung M1, Chiu Y2, Hwang J3, Wang J4
1Department of Public Health, National Cheng Kung University Medical College, Tainan, Taiwan, 2Changhua Christian Hospital, Changhua City, Changhua County, Taiwan, 3Institute of Statistical Science, Academia Sinica, Taipei, Taiwan, 4National Cheng Kung University College of Medicine, Tainan, Taiwan

PHS88
F3
PATIENTS' PERCEPTIONS OF PHYSICIANS' CARING ATTITUDE IS THE CRITICAL FACTOR IN DETERMINING PATIENT SATISFACTION
Park C1, Kim N2, Chung J3, Feldman SR4, Balkrishnan R5, Chang J6
1The University of Texas at Austin, Austin, TX, USA, 2Sookmyung Women's University, Seoul, South Korea, 3Boston University, Boston, MA, USA, 4Wake Forest University, Winston-Salem, NC, USA, 5University of Michigan, Ann Arbor, MI, USA, 6Samford University, Birmingham, AL, USA

PHS89
F4
THE IMPORTANCE OF METHODOLOGY IN REPORTING PERFORMANCE INDICATORS
Chen M1, Levinton C2
1, 2Health Quality Ontario, Toronto, ON, Canada

PHS90
F5
THE CLIENTS' VOICE: SATISFACTION WITH HIV/AIDS CARE IN A PUBLIC AND PRIVATE HEALTH FACILITY IN KABALE DISTRICT, UGANDA
Kwesiga D1, Kiwanuka S2, Kiwanuka N2, Mafigiri D3, Kakande N4
1Global Health Economics Ltd., Kampala, Uganda, 2Makerere School of Public Health, Kampala, Uganda, 3Makerere University School of Social Sciences, Kampala, Uganda, 4Joint Clinical Research Centre, Kampala, Uganda

PHS91
F6
LEAN “INFLOW” CHANGE MAY IMPROVE PRIMARY CARE PATIENT SATISFACTION: A PILOT STUDY
Chen P, Wong E, Hung D
Palo Alto Medical Foundation, Mountain View, CA, USA

PHS92
F7
BELIEFS IN THE EFFECTIVENESS OF SMOKING CESSATION INTERVENTIONS AMONG MALE SAUDI COLLEGE STUDENTS
Almogbel YS, Abughosh S, Sansgiry SS
University of Houston, Houston, TX, USA

PHS93
F8
A WEB-BASED SURVEY TO EVALUATE THE FACTORS ASSOCIATED WITH TREATMENT SEEKING BEHAVIOR IN ADULTS WITH ACNE VULGARIS
Bhattacharya R, Dwibedi N
West Virginia University, Morgantown, WV, USA

PHS94
F9
CREATING THE CANADA PRO NETWORK
Bartlett S1, Ahmed S2
1McGill University, Montreal, QC, Canada, 2McGill University, School of Physical and Occupational Therapy, Montreal, QC, Canada

PHS95
F10
DEVELOPING A COMMUNITY BASED REFERRAL AND COUNTER REFERRAL SYSTEM AS A STRATEGY FOR IMPROVING ANTENATAL, POSTNATAL CARE VISITS AND HEALTH FACILITY DELIVERY, CASE OF KISII COUNTY, RURAL KENYA
Mogere DM, Kaseje D
Great Lakes University of Kisumu, Kisumu, Kenya

PHS96
F11
PREDICTORS OF HEALTH-RELATED QUALITY OF LIFE AMONG ADULTS WITH AUTISM SPECTRUM DISORDERS
Khanna R1, Jariwala K2, West-Strum D1, Mahabaleshwarkar R1
1University of Mississippi, University, MS, USA, 2University of Mississippi, Oxford, MS, USA

PHS97
F12
HEALTH-RELATED QUALITY OF LIFE IN CHRONIC HEPATITIS C PATIENTS WITH DEPRESSION
Sansgiry S1, Pyne J2, Smith D3, Brown A3, Hodges D2, Stanley R2, Kanwal F4
1Center for Innovations in Quality, Effectiveness and Safety, Michael E. Debakey VA Medical Center; Baylor College of Medicine; South Central MIRECC, Houston, TX, USA, 2Central Arkansas Veterans Healthcare System, North Little Rock, TX, USA, 3Center for Innovations in Quality, Effectiveness & Safety Michael E. DeBakey VA Medical Center, Houston, TX, USA, 4Center for Innovations in Quality, Effectiveness & Safety Michael E. DeBakey VA Medical Center; Baylor College of Medicine, Houston, TX, USA

PHS98
F13
QUALITY OF LIFE OF NURSING HOME RESIDENTS IN SINGAPORE
Luo N1, Wang P2, Yap P3, Fong NP1, Koh G1
1National University of Singapore, Singapore, Singapore, 2Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore, 3Khoo Teck Puat Hospital, Singapore

PHS99
WITHDRAWN

PHS100
F14
THE QUALITY OF LIFE AND WORK ABILITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE IN URBAN CHINA
Wu JJ, Yang L
Peking University, Beijing, China

PHS101
F15
STUDY ON WILLINGNESS TO PAY FOR THE CLINICAL PHARMACY SERVICE FOR DIABETES OUTPATIENTS
Long E1, HU M2, Tong R1, Liu J3, Zhang Z2
1Sichuan Provincial People' s Hospital, Chengdu, China, 2Sichuan University, Chengdu, China, 3West China Hospital, Sichuan University, Chengdu, China

HEALTH SERVICES - Health Care Use & Policy Studies
PHS102
F16
UTILIZATION TRENDS OF CANCER PREVENTIVE CARE SERVICES IN THE UNITED STATES: A LONGITUDINAL STUDY OF MEDICAL EXPENDITURE PANEL SURVEY DATA FOR YEARS 1996 TO 2010
Shah A, Bhandari NR, Hwang M
ST. JOHN'S UNIVERSITY, QUEENS, NY, USA

PHS103
G1
PERCEPTIONS OF ACCESS TO HEALTHCARE AND ITS COMPONENTS AND EXPERIENCES WITH CARE DELIVERY: GLOBAL SURVEY OF CITIZENS/PATIENTS FROM 15 COUNTRIES
Narayanan S1, Wright J2
1Ipsos Healthcare, Columbia, MD, USA, 2Ipsos Public Affairs, Toronto, ON, Canada

PHS104
G2
UNDERSTANDING PATTERN OF HEALTH SERVICE UTILIZATION AND ITS PREDICTORS IN ELDERLY PATIENTS IN THAILAND: USING A TWO-PART MODEL
Sruamsiri R1, Chaiyakunapruk N2
1Center of Pharmaceutical Outcomes Research, Naresuan University, Phitsanulok, Thailand, 2Monash University Malaysia, Selangor, Malaysia

PHS105
G3
BREAST AND CERVICAL CANCER SCREENING IN UK: DYNAMIC INTERRELATED PROCESSES?
Labeit A
University of Illinois College of Medicine at Peoria, Peoria, IL, USA

PHS106
G4
EXPLORING THE IMPACT OF CLINICAL, FUNCTIONAL AND SOCIAL FACTORS ON HIP FRACTURE PATIENT HOSPITALIZATION COSTS: INFORMING THE DESIGN OF A NEW CASE MIX PAYMENT SYSTEM
Hellsten EK1, Rais S2, Tsegelsky A2, Malikov K2
1Health Quality Ontario, Toronto, ON, Canada, 2Ministry of Health and Long-Term Care, Toronto, ON, Canada

PHS107
G5
INCREASED IN ACUTE HEALTH CARE USE AMONG PEOPLE LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS (HIV) AND CO-MORBID DEPRESSION IN ONTARIO: A LONGITUDINAL STUDY
Choi S1, Boyle E2, Cairney J3, Carvalhal A4, Collins EJ5, Krahn MD6, Kumar M7, Grootendorst P1, Rourke SB8
1University of Toronto, Toronto, ON, Canada, 2university of southern denmark, Odense, Denmark, 3McMaster University, Hamilton, ON, Canada, 4St. Michael's Hospital, Toronto, ON, Canada, 5University Health Network, Toronto, ON, Canada, 6Toronto Health Economics and Technology Assessment (THETA) Collaborative, Toronto, ON, Canada, 7Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, 8Ontario HIV Treatment Network, Toronto, ON, Canada

PHS108
G6
HOW EFFECTIVE ARE AUSTRALIAN MENTAL HEALTH COUNSELLING SERVICES FOR WOMEN WITH POOR MENTAL HEALTH?
Dolja-Gore X1, Loxton D1, D'este C2, Byles J1
1Research Centre for Gender, Health and Ageing, Newcastle, NSW, Australia, 2Centre for Clinical epidemiology and Biostatistics, Newcastle, NSW, Australia

PHS109
G7
HIGH UTILIZERS OF HEALTHCARE RESOURCES: RESULTS FROM THE MULTICENTER COMPACT STUDY OF COMPLICATIONS IN PATIENTS WITH SICKLE CELL DISEASE AND UTILIZATION OF IRON CHELATION THERAPY
Jordan L1, Adams-Graves P2, Kanter-Washko J3, Oneal P4, Sasane M5, Magestro M5, Marcellari A5, Vekeman F6, Bieri C7, Adams A7, Duh MS8
1University of Miami, Miller School of Medicine, Miami, FL, USA, 2University of Tennessee Health Science Center, Memphis, TN, USA, 3Medical University of South Carolina, Charleston, SC, USA, 4Howard University, Washington, DC, USA, 5Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, 6Groupe d’analyse, Ltée, Montréal, QC, Canada, 7Analysis Group, Inc., Washington, DC, USA, 8Analysis Group, Inc., Boston, MA, USA

PHS110
WITHDRAWN

PHS111
G8
BLOOD PRESSURE TESTING AT COMMUNITY PHARMACIES PROMOTE BETTER HYPERTENSION MANAGEMENT
Taitel M, Lou Y, Huang Z, Nadas J
Walgreen Co., Deerfield, IL, USA

PHS112
G9
MAIL ORDER PHARMACY USE AND ASSOCIATED HEALTH EXPENSES IN ADULTS WITH DIABETES
Noxon V1, Davis-Ajami ML2, Wu J3
1South Carolina College of Pharmacy – USC Campus, Columbia, SC, USA, 2University of Maryland, Baltimore, MD, USA, 3University of South Carolina, Greenville, SC, USA

PHS113
G10
EVALUATION OF A CHRONIC DISEASE MANAGEMENT SYSTEM FOR THE TREATMENT AND MANAGEMENT OF DIABETES IN PRIMARY HEALTH CARE PRACTICES IN ONTARIO
O'Reilly D1, Bowen JM1, Sebaldt R2, Petrie A3, Hopkins RB1, Assasi N2, MacDougald C2, Nunes E4, Goeree R2
1PATH Research Institute, McMaster University, Hamilton, ON, Canada, 2McMaster University, Hamilton, ON, Canada, 3Fig.P. Software Incorporated, Hamilton, ON, Canada, 4St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada

PHS114
G11
DETERMINANTS OF DENTAL CARE UTILIZATION IN ADULT DIABETIC POPULATION
Borse MS1, Holmes M2
1, Chapel Hill, NC, USA, 2UNC Gilling's School of Public Health, Chapel Hill, NC, USA

PHS115
G12
PREDICTORS OF PROSTATE CANCER SCREENING USING ANDERSEN'S BEHAVIORAL MODEL OF HEALTH SERVICES USE
Ogunsanya ME, Jiang S, Thach AV, Bamgbade B, Brown C
The University of Texas at Austin, College of Pharmacy, Austin, TX, USA

PHS116
G13
EIGHT YEARS OF NATIONAL HEALTH INSURANCE IN GHANA: EVALUATION OF THE HEALTH FINANCING SUB-FUNCTIONS
Nsiah-Boateng E
National Health Insurance Scheme, Accra, Ghana

PHS117
G14
IMPACT OF HEALTH PLAN DESIGN AND KEY CHARACTERISTICS ON THE CHOICE OF CONTRACEPTIVE METHOD INITIATED AMONG WOMEN IN AN INTEGRATED HEALTH PLAN
Postlethwaite D1, Armstrong MA1, Darbinian J1, McCoy MA2, Law AW2
1Kaiser Permanente, Oakland, CA, USA, 2Bayer HealthCare Pharmaceuticals Inc, Whippany, NJ, USA

PHS118
G15
MANAGEMENT OF HYPERTENSION IN DIABETICS BY PRIMARY CARE PHYSICIANS AND PREFERENCE OF ANTI-HYPERTENSIVE DRUGS
Rane P, Francis D
University of Houston, Houston, TX, USA

PHS119
G16
PROVISION OF CULTURAL COMPETENCY TRAINING IN THE NATIONAL HOME AND HOSPICE CARE SURVEY: THE ROLE OF ORGANIZATIONAL AND LEADERSHIP FACTORS
AbuDagga A1, Khasawinah S2, Weech-Maldonado R3, Tian F4
1Public Citizen, Washington DC, DC, USA, 2Johns Hopkins Bloomberg School of Public Health, Baltimore, DC, USA, 3University of Alabama at Birmingham, Birmingham, AL, USA, 4HealthCore Inc., Alexandria, VA, USA

PHS120
G17
AN EXAMINATION OF DISPARITY IN ACCESS TO MENTAL HEALTH SERVICES AMONG PEOPLE LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS (HIV) AND CO-MORBID DEPRESSION IN ONTARIO
Choi S1, Boyle E2, Cairney J3, Carvalhal A4, Collins EJ5, Krahn MD6, Kumar M7, Grootendorst P1, Rourke SB8
1University of Toronto, Toronto, ON, Canada, 2university of southern denmark, Odense, Denmark, 3McMaster University, Hamilton, ON, Canada, 4St. Michael's Hospital, Toronto, ON, Canada, 5University Health Network, Toronto, ON, Canada, 6Toronto Health Economics and Technology Assessment (THETA) Collaborative, Toronto, ON, Canada, 7Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, 8Ontario HIV Treatment Network, Toronto, ON, Canada

PHS121
G18
IMPACT OF STATE CHILD AND ADOLESCENT PSYCHIATRIC WORKFORCE ON CAREGIVER REPORTED DIFFICULTY ACCESSING SERVICES FOR CHILDREN WITH MENTAL HEALTHCARE NEEDS
Vohra R1, Madhavan S1, Sambamoorthi U2
1West Virginia University School of Pharmacy, Morgantown, WV, USA, 2West Virginia University, Morgantown, WV, USA

PHS122
G19
RECEIPT OF COLORECTAL CANCER (CRC) SCREENING AMONG MEDICARE BENEFICIARIES WITH SENSORY IMPAIRMENT
Abdulhalim AM1, Soliman AM2, Stuart B1
1University of Maryland School of Pharmacy, Baltimore, MD, USA, 2AbbVie Inc., Libertyville, IL, USA

PHS123
G20
DO CHILDREN WITH SPECIAL NEEDS RECEIVING CARE COORDINATION HAVE GREATER ACCESS TO PRIMARY CARE?
Goyal RK1, Domino ME2, Wells RS3, Kum H3, Hillemeier MM4
1RTI International, Research Triangle Park, NC, USA, 2The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA, 3Texas A&M Health Science Center, College Station, TX, USA, 4The Pennsylvania State University, University Park, PA, USA

PHS124
G21
THE TREND OF CROSS-BOUNDARY FLOW OF EMERGENT CARE IN TAIWAN, 2000–2010
Lin W1, Hsieh C2, Chiou S3, Hsu YE4
1Chang Jung Christian University, Tainan, Taiwan, 2Oriental Institute of Technology, Banciao City,Taipei County, Taiwan, 3National Taipei University of Nursing and Health Sciences, Taipei, Taiwan, 4Taipei Medical University, Taipei, Taiwan

PHS125
H1
WHERE DO VETERANS RECEIVE THEIR CARE FOR NON-TRAUMATIC BONE FRACTURES?
Nelson SD, Willson T, Lafleur J
University of Utah, Salt Lake City, UT, USA

PHS126
H2
DISPARITIES IN RISK OF BANKRUPTCY AMONG PATIENTS DIAGNOSED WITH CANCER
McDougall JA1, Bansal A1, Blough DK1, Fedorenko CR2, Newcomb PA2, Ramsey S2
1University of Washington, Seattle, WA, USA, 2Fred Hutchinson Cancer Research Center, Seattle, WA, USA

PHS127
H3
IMPACT OF THE PAN-CANADIAN PRICING ALLIANCE (PCPA) ON ACCESS TO DRUG TREATMENT OPTIONS FOR CANADIAN PATIENTS
Luciani L1, Gregory V2, Barbeau M3
1Université de Montréal, Montreal, QC, Canada, 2Novartis Pharmaceuticals Canada Inc., Dorval, QC, Canada, 3Novartis Pharmaceuticals Canada Inc., Montreal, QC, Canada

PHS128
H4
CORRELATION BETWEEN MULTIDIMENSIONAL POVERTY INDEX, INEQUITY IN HEALTH AND SOCIAL INEQUALITY VARIABLES IN COLOMBIA. YEAR 2005
Sandoval Vargas G, Eslava-Schmalbach J, Saboya D, Romero F
Universidad Nacional de Colombia, Bogotá, Colombia

PHS129
H5
ISSUES AND PROGRESS OF HEALTH SYSTEMS IN THE MAGHREB COUNTRIES
Mahi L1, Kettani A2
1Axelys Sante Affaires Medicales et Recherche Clinique, Paris, France, 2Stratance Health, Agdal - Rabat, Morocco

PHS130
H6
UNDERSTANDING THE UNDERUTILIZATION OF COLORECTAL CANCER SCREENING USING THE 2009-2011 MEDICAL EXPENDITURE PANEL SURVEY (MEPS)
Singh RR, Olotu B, Lawson KA
The University of Texas at Austin, Austin, TX, USA

PHS131
H7
FACTORS ASSOCIATED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE-RELATED INPATIENT READMISSIONS
Meyers J1, Yu Y2, Kaila S2, Dhamane A2, Candrilli SD1
1RTI Health Solutions, Research Triangle Park, NC, USA, 2Boehringer-Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA

PHS132
H8
HOSPITALIZATION FOR BICYCLE-RELATED INJURIES IN TAIWAN, 2007-2011
Yang M, LI YF
National Taiwan University, Taipei, Taiwan

PHS133
H9
VALUE OF A ZERO-COPAY DRUG PROGRAM: IMPLICATION FOR EMPLOYEE WELLNESS PROGRAMS
Pitcavage JM1, Tomcavage J2, Jones JB3, Maeng DD4
1The Pennsylvania State University, University Park, PA, USA, 2Geisinger Health Plan, Danville, PA, USA, 3Sutter Health System, Walnut Creek, CA, USA, 4Geisinger Health System, Danville, PA, USA

PHS134
H10
HEALTHCARE SPENDING PATTERNS IN HIGH RESOURCE PATIENTS
Pritchard DE1, Petrilla AA2, Hallinan S2, Taylor Jr. DH3, Schabert VF2, Dubois RW1
1National Pharmaceutical Council, Washington, DC, USA, 2IMS Health, Alexandria, VA, USA, 3Duke University, Durham, NC, USA

PHS135
H11
READMISSION TO A DIFFERENT HOSPITAL – RISK FACTORS AND IMPACT ON LENGTH OF STAY
Flaks-Manov N1, Shadmi E2, Bitterman H3, Balicer RD4
1Clalit Research Institute, Tel Aviv, Israel, 2University of Haifa, Tel-Aviv, Israel, 3Clalit Health Services Headquarters, Tel-Aviv, Israel, 4Clalit Health Services, Tel Aviv, Israel

PHS136
H12
THE IMPACT OF PHARMACIST-DELIVERED VACCINATION ON INFLUENZA IMMUNIZATION RATES AND PERCEPTION IN CANADA: AN ECOLOGICAL STUDY
Patel A1, Marra C1, Lalji F2, Law M3, Lester R1
1University of British Columbia, Vancouver, BC, Canada, 2University of Britsih Columbia, Vancouver, BC, Canada, 3University of British Columbia, Vancouver, BC, USA

PHS137
H13
A RISK STRATIFICATION TOOL FOR SCREENING FOR DIABETIC RETINOPATHY AMONG TYPE 2 DIABETIC PATIENTS
Sun Y1, Paul P2, Tan N3, Rajagopalan R3, Lew Y4, Heng BH5
1National Healthcare Group, Singapore, Singapore, Singapore, 2National Healthcare Group, Singapore, Singapore, 3Tan Tock Seng Hospital, Singapore, Singapore, 4National Healthcare Group Polyclinics, Singapore, Singapore, 5National healthcare Group, Singapore, Singapore

PHS138
H14
ASSESSMENT OF MANAGEMENT AND LEADERSHIP SKILLS ,COMPETENCIES AND ABILITY AMONG HEALTH CARE MANAGERS WORKING IN LEVEL 3,4 AND 5 HOSPITALS , NYANZA PROVINCE -KENYA
Mogere DM, Muga R
Great Lakes University of Kisumu, Kisumu, Kenya

PHS139
H15
CLINICAL OUTCOMES OF A PHARMACIST AND NURSE PILOT INTERVENTION IN A COMMERCIAL POPULATION
Lee JS1, Sun P1, Chuang A1, Chung S1, Stockl KM1, Lew HC1, Curtis B1, Solow B1, Bland P2, Coleman R2, Den Hartog KS2
1OptumRx, Irvine, CA, USA, 2OptumHealth, Golden Valley, MN, USA

PHS140
H16
ROLES FOR PHARMACISTS IN PATIENT CENTERED MEDICAL HOMES: SUCCESSES AND BARRIERS
Kim D, Lovett A
Mercer University, Atlanta, GA, USA

PHS141
H17
GENDER MEDICINE AND HEALTH INSURANCE POLICY: AN EMPIRICAL STUDY IN GERMANY GENDER MEDICINE AND HEALTH INSURANCE POLICY: AN EMPIRICAL STUDY IN GERMANY
Chase DP1, Mitar I2, Oertelt-Prigione S3, Hess N4, Amelung VE1
1Institute for Applied Health Services Research, Berlin, Germany, 2Pfizer Pharma GmbH, Berlin, Germany, 3Charité Berlin, Berlin, Germany, 4Private Practice, Berlin, Germany

PHS142
H18
TREATMENT PATTERNS OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Dugel PU1, Arnold RJ2, Layton AJ2
1Retina Consultants of Arizona, Phoenix, AZ, USA, 2Quorum Consulting, Inc., San Francisco, CA, USA

PHS143
WITHDRAWN

PHS144
H19
ASSESSING THE EFFECT OF A COST-MANAGEMENT COMPONENT IN A TARGETED INTERVENTION PROGRAM
Zhang Y1, Doucette WR1, Pendergast JF1, Brown GD1, Frank J2
1The University of Iowa, Iowa City, IA, USA, 2OutcomesMTM, West Des Moines, IA, USA

PHS145
H20
USE OF ACUPUNCTURE AND ASSOCIATED FACTORS AMONG THE ELDERLY: A RETROSPECTIVE POPULATION-BASED COHORT STUDY
Lin H1, Chen L1, Lin C2, Chou C2
1China Medical University, Taichung, Taiwan, 2China Medical University Hospital, Taichung, Taiwan

PHS146
WITHDRAWN

PHS147
H21
WHAT DETERMINANTS HELP PREDICT READMISSION IN A TEACHING HOSPITAL
Emmanuel J1, Ma L1, Saleh S1, Wilkinson H1, Raichura H1, Wilson L2
1Royal London Hospital, London, UK, 2Royal London Hospital NHS Trust, London, UK

PHS148
I1
BREAST CANCER INTEGRATED CARE: A RAPID-HTA
Cachoeira CV, Andrade PC, Junqueira SM, Repsold DM
Johnson & Johnson Medical, São Paulo, Brazil

PHS149
I2
THE AFFORDABLE CARE ACT AND PHARMACY BENEFIT MANAGERS: HEALTHCARE EXCHANGES AND PROJECTED OUTCOMES
Shamseddine N1, Lovett AW1, Beaty S2
1Mercer University College of Pharmacy, Atlanta, GA, USA, 2Express Scripts, St. Louis, MO, USA

PHS150
I3
IMPACT OF EDUCATIONAL INTERVENTION ON QUALITY OF LIFE OF PATIENTS NEARING END OF LIFE: AN EVIDENCE BASED ANALYSIS
Nevis IF, Sikich N, Holubowich C
on behalf of the Health Quality Ontario Expert Panel on End-of-Life Care, Health Quality Ontario, Toronto, ON, Canada

PHS151
I4
MAMMOGRAPHY PRSCRIPTIONS IN U.S. PRIMARY CARE SETTING - PHYSICIAN'S COMPLIANCE WITH GUIDELINES
Suryavanshi M, Lairson DR, Rajan SS
University of Texas Health Science Center, School of Public Health, Houston, TX, USA

PHS152
I5
THE IMPACT OF MISSED CLINIC APPOINTMENTS ON THE QUALITY OF ANTICOAGULATION CONTROL IN AN INNER-CITY UNDERSERVED MINORITY POPULATION
Sarangpur S, Sharp L, Gerber B, Schumock GT, Fitzgibbon ML, Cavallari LH, Bathija S, Nutescu E
University of Illinois at Chicago, Chicago, IL, USA

PHS153
I6
EFFECTIVENESS OF PATIENT CARE PLANNING DISCUSSIONS IN IMPROVING PATIENT-CENTRED OUTCOMES FOR END-OF-LIFE CARE: AN EVIDENCE-BASED ANALYSIS
Baidoobonso SM1, Holubowich C2
1Health Quality Ontario, Toronto, ON, Canada, 2on behalf of the Expert Panel on End-of-Life Care, Health Quality Ontario, Toronto, ON, Canada

PHS154
I7
RELATIONSHIP BETWEEN MEDICAID ELIGIBILITY AND TIME TO RE-INCARCERATION OF PREVIOUSLY INCARCERATED SUBJECTS WITH SCHIZOPHRENIA
Benson C1, Dickson M2, Kozma CM3, Pesa JA1
1Janssen Scientific Affairs, LLC, Titusville, NJ, USA, 2Presbyterian College School of Pharmacy, Clinton, SC, USA, 3CK Consulting Associates, LLC, St. Helena Island, SC, USA

PHS155
I8
MULTI-OPIOID, MULTI-PROVIDER USE IN PERSONS WITHOUT CANCER
Shahpurwala Z1, Null KD1, Clark JP2
1University of Mississippi, University, MS, USA, 2Mississippi Division of Medicaid, Jackson, MS, USA

PHS156
I9
DEPRESSION AND AMBULATORY CARE SENSITIVE HOSPITALIZATIONS AMONG MEDICARE BENEFICIARIES WITH CHRONIC PHYSICAL CONDITIONS
Bhattacharya R1, Shen C2, Sambamoorthi U3
1West Virginia University, Morgantown, WV, USA, 2The University of Texas MD Anderson Cancer Center, Houston, TX, USA, 3West Virginia University School of Pharmacy, Morgantown, WV, USA

PHS157
I10
ASSESSMENT OF SPIROMETRY TESTING AND INPATIENT READMISSION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Yu Y1, Meyers J2, Kaila S1, Dhamane A1, Candrilli SD2
1Boehringer-Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA, 2RTI Health Solutions, Research Triangle Park, NC, USA

PHS158
I11
DEVELOPMENT AND EVALUATION OF A POST-DISCHARGE MEDICATION RECONCILIATION PROGRAM
Harrington AR, Calabro K, Boesen K, Warholak TL
University of Arizona, Tucson, AZ, USA

PHS159
I12
KNOWLEDGE, ATTITUDES AND PRACTICE PERTAINING TO DEPRESSION AMONG GENERAL PRACTITIONERS IN AN INDIAN CITY
Dhingra S1, Parle M2, Sachdeva M3, Maharaj S1, Pandey S1
1The University of the West Indies, St. Augustine, Trinidad and Tobago, 2Guru Jambheshwar University of Science and Technology, Hisar, India, 3Panjab University, Chandigarh, India

PHS160
I13
DEVELOPING A POPULATION-BASED PALLIATIVE AND END-OF-LIFE CARE DECISION-ANALYTIC POLICY MODEL
Pham B1, Fowler R2, Tanuseputro P3, Manuel D3, Sikich N4, Baidoobonso SM5, Pechlivanoglou P1, Krahn MD1
1Toronto Health Economics and Technology Assessment (THETA) Collaborative, Toronto, ON, Canada, 2Sunnybrook Research Institute, Toronto, ON, Canada, 3Ottawa Hospital Research Institute, Ottawa, ON, Canada, 4on behalf of the Health Quality Ontario Expert Panel on End-of-Life Care, Health Quality Ontario, Toronto, ON, Canada, 5Health Quality Ontario, Toronto, ON, Canada

PHS161
I14
LOW INCIDENCE OF VENOUS THROMBOEMBOLISM IN MOBILE POPULATIONS
Emmanuel J1, Wells M1, Raichura H1, Gunawan A1, Mcloughlin T1, Mullish B1, Wilson L2
1Royal London Hospital, London, UK, 2Royal London Hospital NHS Trust, London, UK

PHS162
WITHDRAWN

PHS163
I15
COMPARING PUBLIC INFLUENZA IMMUNIZATION PROGRAMMES IN ONTARIO AND QUÉBEC, CANADA
Iskedjian M1, Desjardins B2, Walker JH3
1Université de Montréal, Montréal, QC, Canada, 2Independent Consultant, Ste-Thérèse, QC, Canada, 3Brock University, St. Catharines, ON, Canada

PHS164
I16
TRENDS IN MEDICARE PART D MEDICATION THERAPY MANAGEMENT ELIGIBILITY CRITERIA
Qin Y1, Young T2, Wang J3, Thomas Z4, Spivey CA3, Chisholm-Burns M4, Solomon DK4
1Duke University, Memphis, TN, USA, 2The University of Mississippi, Memphis, TN, USA, 3The University of Tennessee College of Pharmacy, Memphis, TN, USA, 4The University of Tennessee Health Science Center, Memphis, TN, USA

PHS165
I17
THE IMPLEMENTATION OF MEDICARE PART D AND THE HEALTH IMPLICATIONS OF MEDICATION THERAPY MANAGEMENT ELIGIBILITY CRITERIA
Wang J1, Qiao Y1, Shih YT2, Spivey CA1, Wan JY3, White-Means SI3, dagogo-Jack S3, Cushman WC3, Chisholm-Burns M3
1The University of Tennessee College of Pharmacy, Memphis, TN, USA, 2University of Chicago, Chicago, IL, USA, 3The University of Tennessee Health Science Center, Memphis, TN, USA

PHS166
I18
POTENTIAL EFFECTS OF RACIAL AND ETHNIC DISPARITIES IN MEETING MEDICARE
Wang J1, Qiao Y1, Shih YT2, Spivey CA1, Wan JY3, White-Means SI3, dagogo-Jack S3, Cushman WC3, Chisholm-Burns M3
1The University of Tennessee College of Pharmacy, Memphis, TN, USA, 2University of Chicago, Chicago, IL, USA, 3The University of Tennessee Health Science Center, Memphis, TN, USA

PHS167
I19
OUTPATIENT VISITS TO THE CATH LAB FOR CORONARY ANGIOGRAPHY RESULTING IN MINIMAL ACTION IN THE SHORT TERM
Mallow PJ1, Rowlandson I2, Tasic D2
1S2 Statistical Solutions, Cincinnati, OH, USA, 2GE Healthcare, Wauwatosa, WI, USA

PHS168
I20
EFFECT OF INPATIENT ADMISSIONS ON TREATMENT REGIMENS IN PATIENTS WITH TYPE 2 DIABETES
Ellis JJ1, Bouchard JR2, Saundankar V1, Baltz J3, Meah Y3, Moretz C1
1Comprehensive Health Insights, Louisville, KY, USA, 2Novo Nordisk, Inc., Plainsboro, NJ, USA, 3Humana Inc., Louisville, KY, USA

PHS169
I21
RESOURCE USE AND OUTCOMES OF TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN RUSSIA: A RETROSPECTIVE FIELD STUDY
Samyshkin Y1, Roberts CS2, Koroleva N3, Rodionov A4
1IMS Health, London, UK, 2Pfizer Inc., New York, NY, USA, 3Sechenov Moscow Medical University, Moscow, Russia, 4Tver State Medical Academy, Tver, Russia

PHS170
J1
RHEUMATOID ARTHRITIS PATHWAY PROGRAM IMPACT ON PATTERNS OF CARE
Feinberg BA1, Olson T1, Matsumoto AK2, Baraf HS2, Miller PB3, Winn D3
1Cardinal Health, Dublin, OH, USA, 2Arthritis and Rheumatism Associates, Wheaton, MD, 3CareFirst BlueCross BlueShield, Baltimore, MD, USA

Contact ISPOR @ info@ispor.org | View Legal Disclaimer
© 2018 International Society for Pharmacoeconomics and Outcomes Research.
All rights reserved under International and Pan-American Copyright Conventions.